In addition, comparison of EML4-ALK rearrangement with the KRAS mutations in the same NSCLC samples revealed that the EML4-ALK fusion gene was mutually exclusive of the KRAS mutations. This evidence concerns the gene ALK and non-small cell lung carcinoma.